|
Available Programs and Courses
FOR Physician
|
|
A complete listing of currently available online programs is provided below. To view course materials click an available viewing format provided with each listing (PDF, HTML, Interactive). To access online exams and claim credit you must be registered and logged in. To add courses to your "MyAR Archives" user account select the "Add To Cart" button provided with each course title and follow the prompts.
|
A Multimodality Approach to Imaging the Mediastinum and Pleura: Pearls and Pitfalls
|
|
Released:
March 01, 2020
•Expires:
February 28, 2022
|
CE credits:
1.0
• Cost:
$0.00
|
|
Faculty:
Applied Radiology
|
Leonid Roshkovan, MD; Sharyn I. Katz, MD, MTR
Diagnostic interpretation of cross-sectional imaging of the mediastinum and pleura presents unique and significant challenges even to the experienced radiologist. The mediastinum is anatomically complex, comprising numerous structures ar-ranged into multiple anatomic compartments that can give rise to a wide range of pathologies. The pleural space is thin and multi-planar, which can confound evaluation and quantification of pleural abnormalities.
In this article, we will review imaging approaches to the mediastinum and pleura and present imaging pearls and pitfalls that can assist radiologic interpretation. This will include common masses that present in routine imaging of the chest and key imaging features that help to distinguish them using CT, MRI and FDG-PET/CT.
The knowledge of common mediastinal and pleural pa-thologies present on cross-sectional imaging will enable the radiologist to make informed diagnostic radiologic interpreta-tions and guide appropriate intervention and surveillance.
Available for SA-CME Credit. To receive SA–CME credit, you must complete the post exam and review the discussion and references provided with the exam results.
|
|
|
|
|
MRI Screening for Hepatocellular Carcinoma
|
|
Released:
July 01, 2020
•Expires:
June 30, 2022
|
CE credits:
1.0
• Cost:
$0.00
|
|
Faculty:
Applied Radiology
|
Courtney C Moreno, MD; Thuy-Van P Hang, MD; Joel P Wedd, MD, MPH
Screening for hepatocellular carcinoma (HCC) has been shown to improve overall survival by detecting earlier stage, more treatable disease. For some patients with HCC, liver transplant is the preferred treatment. However, donor livers are a scarce resource. Accurate identification and description of HCC with MRI is important in the determination of which patients will receive a liver transplant.
This article reviews background information about cirrhosis and hepatocellular carcinoma, the role of screening, transplant priority determination, and diagnostic criteria for HCC.
Available for SA-CME Credit. To receive SA–CME credit, you must complete the post exam and review the discussion and references provided with the exam results.
|
|
|
|